CFP BioConnect, the life sciences arm of the Corporate Finance Partners Group, is pleased to announce that it has advised Minapharm Pharmaceuticals, Cairo/Egypt (http://www.minapharm.com/) on the acquisition of a 95% stake in ProBioGen AG, Berlin/Germany (http://www.probiogen.de/). The total purchase price of EUR 30.4 million includes earn-out payments which are conditional upon the achievement of defined milestones. HC Securities & Investment, Cairo (http://www.hc-si.com/), acted as co-advisor, Hengeler Mueller was legal counsel and Ernst & Young was responsible for the financial due diligence.

Minapharm Pharmaceuticals, headquartered in Cairo, is one of the leading pharmaceutical companies in Egypt and the Middle East. Through its subsidiary, Rhein Minapharm BioGenetics, Minapharm has established a meaningful presence in the biologicals area and has already successfully launched five therapeutic proteins on the market.

ProBioGen is a well established specialist in mammalian cell-engineering and cell culture as well as a leading innovator in the field of designer cell lines. The Company will continue to offer its customers a fully integrated and complete service spectrum from gene to market supply, providing every step from protein expression to cGMP manufacturing, including full project management support. ProBioGen provides Minapharm with an excellent platform to further expand its business into Europe.

We are extremely proud to link our name to Minapharm Pharmaceuticals, one of the fastest growing companies in the MENA (Middle East North Africa) region with high ambitions to grow its business in the European market place. This transaction also underpins CFP BioConnect’s global reach and, once again, its ability to initiate and execute cross-border M&A transactions on a truly international level.

For further information on this transaction, or CFP BioConnect’s scope of advisory services in Corporate Finance and M&A, please contact:
Corporate Finance Partners CFP BioConnect AG
Klaus Nestler, klaus8e5dfefa43724b6da9d85ef5c638a549.nestler@e0280d92692542899e4889195108e1e3cfpartners.com 
Richard Chambers, richarde53559e445a145d98dd17e16ebeecbc7.chambers@53a2275080e646469946b46ca5b1f0cfcfpartners.com 
Niedenau 36, 60325 Frankfurt
Phone: +49 (69) 907466 0
Fax: +49 (69) 907466 20